Abstract
Purpose of review: Establishing an early, efficient diagnosis for cardiac amyloid (CA) is critical to avoiding adverse outcomes. We review current imaging tools that can aid early diagnosis, offer prognostic information, and possibly track treatment response in CA. Recent findings: There are several current conventional imaging modalities that aid in the diagnosis of CA including electrocardiography, echocardiography, bone scintigraphy, cardiac computed tomography (CT), and cardiac magnetic resonance (CMR) imaging. Advanced imaging techniques including left atrial and right ventricular strain, and CMR T1 and T2 mapping as well as ECV quantification may provide alternative non-invasive means for diagnosis, more granular prognostication, and the ability to track treatment response. Summary: Leveraging a multimodal imaging toolbox is integral to the early diagnosis of CA; however, it is important to understand the unique role and limitations posed by each modality. Ongoing studies are needed to help identify imaging markers that will lead to an enhanced ability to diagnose, subtype and manage this condition.
Original language | English (US) |
---|---|
Pages (from-to) | 43-63 |
Number of pages | 21 |
Journal | Current Treatment Options in Cardiovascular Medicine |
Volume | 25 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2023 |
Keywords
- Bone scintigraphy
- Cardiac amyloidosis
- Echocardiography
- Light-chain amyloidosis
- Magnetic resonance imaging
- Transthyretin
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine